4//SEC Filing
Branning Todd P. 4
Accession 0001209191-20-004719
CIK 0001723128other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:42 PM ET
Size
9.3 KB
Accession
0001209191-20-004719
Insider Transaction Report
Form 4
Branning Todd P.
SVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2020-01-22+20,096→ 20,096 total - Tax Payment
Class A Common Stock
2020-01-22$5.13/sh−7,311$37,505→ 12,785 total - Exercise/ConversionSwap
Restricted Stock Units
2020-01-22−20,096→ 60,290 total→ Class A Common Stock (20,096 underlying)
Footnotes (4)
- [F1]Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F3]Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
- [F4]On January 22, 2019, the reporting person was granted 80,386 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. The restricted stock units do not expire.
Documents
Issuer
Amneal Pharmaceuticals, Inc.
CIK 0001723128
Entity typeother
Related Parties
1- filerCIK 0001765274
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:42 PM ET
- Size
- 9.3 KB